We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ultrasound Fusion Imaging Provides Comparable Accuracy as CT, MRI for Bone, Soft Tissue Tumors

By HospiMedica International staff writers
Posted on 03 Mar 2011
Biopsies using ultrasound fusion imaging for detecting bone and soft tissue cancers are safe, effective, and just as accurate as conventional biopsy methods, according to new findings. More...


Researchers from Henry Ford Hospital (Detroit, MI, USA) revealed that the ultrasound fusion imaging technique guides a needle biopsy with precise accuracy and ease, while making the biopsy experience more convenient for patients.

Ultrasound fusion merges real-time ultrasound images with previously acquired computed tomography (CT) or magnetic resonance imaging (MRI) scans, providing physicians with high resolution, life-like imaging to identify the area for biopsy. This is the first time researchers compared the safety and effectiveness of ultrasound fusion against conventional biopsy imaging tools such as CT or MRI.

The study's findings are presented at the annual meeting of the American Academy of Orthopedic Surgeons February 15-18, 2011, in San Diego (CA, USA). "Ultrasound fusion is a viable option to consider for patients," said Michael Mott, MD, an orthopedic oncologist at Henry Ford and lead investigator for the study. "With imaging precision being equal, patients liked the ultrasound fusion because scheduling a biopsy was found to be more flexible for ultrasound suites than CT suites."

Bone and soft tissue cancers account for a small number of cancer cases. According to the US National Cancer Institute (Bethesda, MD, USA), about less than 1% of all new cancer cases occur each year in the United States.

Henry Ford researchers compared the results of 44 patients from January to December in 2010 who were randomized into one of two groups: those who received an ultrasound fusion biopsy and those who received a CT biopsy. Researchers also looked at the time and ease of obtaining the biopsy and outcomes. Dr. Mott reported that the accuracy for obtaining the ultrasound fusion biopsy was 93% compared to 90% for obtaining the CT biopsy. Researchers also discovered that the ultrasound fusion was as safe and effective as the CT biopsy.

The study was funded by Henry Ford Hospital and GE Healthcare (Chalfont St. Giles, UK).

Related Links:

Henry Ford Hospital




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Silver Member
ECG Management System
NEMS Web
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.